DIVISLAB — Divi's Laboratories Share News
0.000.00%
- IN₹3.04tn
- IN₹3.02tn
- IN₹105.60bn
India's Biocon up as unit's eye drug to be launched in Canada by mid-2025
India's Divi's Laboratories up on higher Q3 profit; top Nifty Pharma gainer
Preview: India's Sun Pharma rises ahead of Q3 results
FMCG, energy stocks drag India's Nifty, Sensex
Analysts most bearish on Indian IT among Nifty 50 stocks
India's Nifty gains, seen finding resistance at 21,500
Indian pharma cos could see sustained margin expansion in near term - Bernstein
Brief: Divi's Laboratories Receives Order Pertaining To Recovery Of Refund Of IGST Granted
India's Divi's Labs down on Q2 profit miss
India's Divi's Labs misses profit estimates on higher expenses
Brief: India's Divi’s Laboratories Posts Q2 Consol Net Profit 3.48 Billion Rupees
Brief: Divi's Laboratories Says USFDA Delegation Visits Company's Unit
Madhusudana Rao Divi To Retire As Whole-Time Director
Street View-India's Divi's Labs to see growth triggers but risks remain
India's Divi's Labs Q1 profit slumps on drug pricing pressures
India's Divi's Labs down on Q1 profit slump
Brief: India's Divi's Laboratories Q1 Consol Net Profit 3.56 Billion Rupees
India's Divi's Labs up 3% on upbeat analysts' views
India's Divi's Laboratories up in a weak market on positive growth view